Protecting patients by advocating safe, effective, affordable drugs and medical devices
Prescription drugs are unaffordable and new drugs and devices often are approved without being proven safe and effective. Public Citizen challenges Big Pharma, device manufacturers and federal regulators to make drugs and medical devices safe, effective and accessible to all.
What you can do
Our doctors and policy experts use research and advocacy to push for safe and effective drugs and medical devices, and to lower the cost of drugs and make them accessible to all.
Worst Pills, Best Pills
WorstPills.org and Worst Pills, Best Pills News provide expert, independent opinions on more than 1,800 prescription drugs, over-the-counter medications and supplements.
Access to Medicines
We work with partners worldwide to improve health outcomes and save lives through pharmaceutical cost-lowering measures including generic competition.
Outrage Of The Month: FDA Approval of Brexpiprazole for Agitation Symptoms Associated With Dementia Due to Alzheimer’s Disease — False Hopes for Patients and Families?
Civil Society Organizations Comment to Center for Medicare: Therapeutic Alternative Prices as Starting Point in Drug Price Negotiations
Testimony before the FDA’s Gastrointestinal Drugs Advisory Committee regarding the possible accelerated approval of obeticholic acid (NDA# 212833) to treat nonalcoholic steatohepatitis with fibrosis
Testimony before the FDA’s Cellular, Tissue and Gene Therapies Advisory Committee Regarding SRP-9001 (delandistrogene moxeparvovec) for the Treatment of Duchenne Muscular Dystrophy
Sidney Wolfe, MD
Health Research Group Founder and Senior Adviser
Michael Abrams, M.P.H., Ph.D.
Senior Health Researcher
Access to Medicines Director
Campaign Director, Global Vaccines Access
Azza AbuDagga, MHA, Ph.D.
Health Services Researcher